Investor

Investor Webinar | Emyria and Cann Group Partnership

Apr 09, 2021

Investor Webinar | Emyria and Cann Group Partnership

Contact Us

Phone 1300 436 363

Email info@emyria.com

Recent Tweets

📽️Emyria has received TGA approval for #Openly heart rate monitoring app. MD, Dr mwinlo explains what a Class IIa… https://t.co/ACiY8yZ6Q3

Emyria's MD, mwinlo speaks to proactive_au's AndrewScottTV following the news we have been awarded TGAgovau app… https://t.co/mozma5YUwd

$EMD has received TGAgovau approval for its #Openly app, which will be used in several upcoming clinical trials an… https://t.co/amzORCYikV